Core Viewpoint - Julie & Holleman LLP is investigating potential claims against Stride, Inc. insiders due to significant losses suffered by the company's stockholders, linked to alleged fraudulent activities and governance failures [1][3]. Group 1: Allegations Against Stride, Inc. - Stride and its executives are accused of engaging in a massive cover-up, failing to disclose critical issues regarding the company's business performance and future prospects [2]. - Specific allegations include the failure to disclose inflated enrollment figures, retention of "ghost students" to secure state funding, non-compliance with staffing requirements, and declines in customer experience alongside increasing withdrawal rates [2]. Group 2: Impact on Stock Performance - Following the revelation of these issues, Stride's stock experienced a significant decline, indicating a loss of investor confidence and potential financial repercussions for shareholders [3]. Group 3: Legal Actions and Firm Background - Julie & Holleman LLP has a history of securing hundreds of millions of dollars for shareholders in similar cases and is now focusing on potential legal claims against Stride, its executives, and possibly the board of directors [3][4].

Core Viewpoint - The Fermi Inc. class action lawsuit alleges violations of securities laws related to its October 2025 IPO, with claims of misleading statements regarding tenant demand and funding commitments for its Project Matador campus [2][4]. Group 1: Class Action Details - The class action lawsuit is titled Lupia v. Fermi Inc., No. 26-cv-00050 (S.D.N.Y.) and involves Fermi, its executives, and IPO underwriters [2]. - Investors who purchased Fermi common stock during the IPO or between October 1, 2025, and December 11, 2025, can seek to be appointed as lead plaintiff by March 6, 2026 [1][7]. Group 2: Allegations Against Fermi - The lawsuit claims that Fermi overstated tenant demand for its Project Matador campus and failed to disclose reliance on a single tenant's funding commitment [4]. - It is alleged that there was a significant risk of the tenant terminating its funding commitment, which was not disclosed [4]. - On December 12, 2025, Fermi announced that the first tenant for Project Matador had terminated a $150 million funding agreement, leading to a nearly 34% drop in stock price [5]. Group 3: Stock Performance - Following the IPO, Fermi's stock price fell from $21.00 per share to as low as $8.59 per share, representing a 59% decline [6]. Group 4: Law Firm Background - Robbins Geller Rudman & Dowd LLP is a leading law firm in securities fraud and shareholder litigation, having recovered over $2.5 billion for investors in 2024 alone [8].

Core Viewpoint - The F5 class action lawsuit alleges that F5, Inc. and its executives misled investors regarding the company's revenue outlook and growth potential, particularly in light of a significant security breach that impacted its operations and stock price [3][4][5]. Group 1: Allegations and Impact - The lawsuit claims that F5 created a false impression of having reliable information about its projected revenue and growth while downplaying risks associated with seasonality and macroeconomic factors [3]. - It is alleged that F5 was experiencing a major security incident that jeopardized both client security and the company's future prospects [3]. - Following the disclosure of a security breach on October 15, 2025, F5's stock price dropped nearly 14% over two trading days [4]. - On October 27, 2025, F5 reported fourth-quarter fiscal year 2025 results that fell significantly below market growth expectations for fiscal 2026, attributing this to the security breach, which led to an 11% decline in stock price over two trading days [5]. Group 2: Company Overview - F5 is described as a global multi-cloud application security and delivery company that enables customers to deploy, secure, and operate applications both on-premises and via public cloud [2]. - The company's flagship product, BIG-IP, was notably affected by the security breach, which is also its highest revenue-generating product [5]. Group 3: Legal Process - The Private Securities Litigation Reform Act of 1995 allows any investor who purchased F5 securities during the Class Period to seek appointment as lead plaintiff in the class action lawsuit [6]. - The lead plaintiff is typically the investor with the greatest financial interest in the case and acts on behalf of all other class members [6]. Group 4: Law Firm Background - Robbins Geller Rudman & Dowd LLP is a leading law firm specializing in securities fraud and shareholder litigation, having secured over $2.5 billion for investors in 2024 alone [7]. - The firm has been recognized for its significant recoveries in securities class action cases, including the largest recovery in history of $7.2 billion in the Enron case [7].

If you suffered substantial losses and wish to serve as lead plaintiff of the Fermi class action lawsuit, please provide your information here: SAN DIEGO, Jan. 6, 2026 /PRNewswire/ -- Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Fermi Inc. (NASDAQ: FRMI): (i) common stock pursuant and/or traceable to the registration statement and prospectus issued in connection with Fermi's October 2025 initial public offering ("IPO"); and/or (ii) securities between October 1, 2025 and Decembe ...

Core Viewpoint - A class action lawsuit has been filed against Agilon Health, Inc. concerning allegations of securities fraud and unlawful business practices [2]. Group 1: Lawsuit Details - Investors are encouraged to contact Pomerantz LLP for participation in the class action, with a deadline to apply as Lead Plaintiff by March 2, 2026 [2]. - The lawsuit pertains to actions taken by Agilon and certain officers and/or directors during the Class Period [2]. Group 2: Company Performance and Management Changes - On August 4, 2025, Agilon announced the resignation of Steven Sell as President, CEO, and Director of the Board [4]. - The same day, Agilon reported its second-quarter financial results, indicating that industry challenges were more severe than anticipated, leading to the suspension of its full-year 2025 financial guidance [4]. - Following these announcements, Agilon's stock price dropped by $0.94 per share, or 51.52%, closing at $0.88 per share on August 5, 2025 [4].

Core Viewpoint - A class action lawsuit has been filed against Charming Medical Ltd. for alleged securities fraud and unlawful business practices [2]. Group 1: Lawsuit Details - The lawsuit involves allegations that Charming and certain officers and/or directors engaged in securities fraud [2]. - Investors have until February 17, 2026, to request to be appointed as Lead Plaintiff if they purchased Charming securities during the Class Period [2]. Group 2: Stock Performance and SEC Action - On November 11, 2025, Charming's stock closed at $29.36, with an intraday high of $31.70, and had approximately 17.18 million shares outstanding, resulting in a market capitalization of around $504 million [4]. - Following this, the SEC halted trading of Charming securities from November 12 through 25, 2025, due to allegations of price manipulation through social media, which was part of a "pump-and-dump" scheme [4].

Core Viewpoint - A class action lawsuit has been filed against Smartsheet Inc. regarding allegations of securities fraud and unlawful business practices related to a recent merger [1][2]. Group 1: Lawsuit Details - The lawsuit claims that Smartsheet and certain officers and directors engaged in securities fraud during the solicitation of stockholder approval for a merger with investment funds managed by Blackstone, Vista Equity Partners, and others [4][5]. - Investors have until February 24, 2026, to request to be appointed as Lead Plaintiff if they purchased Smartsheet securities during the class period [2]. Group 2: Allegations Against Smartsheet - The complaint alleges that Smartsheet issued a misleading Schedule 14A Proxy statement to the U.S. Securities and Exchange Commission, mischaracterizing the company's financial performance to solicit approval for the merger [5]. - The Proxy allegedly presented the company's quarterly earnings negatively and emphasized a financial metric created specifically for the merger approval process [5]. Group 3: Financial Implications - The merger consideration was set at $56.50 per share, which was within the range of a discounted cash flow analysis but below several analyst price targets that had been raised following the company's successes in early 2024 [6].

NEW YORK, Jan. 06, 2026 (GLOBE NEWSWIRE) -- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized investor-rights law firm, announces that a class action lawsuit has been filed against Fermi Inc. (NASDAQ: FRMI) and certain of its officers. This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired Fermi securities: (1) pursuant to the registration statement and prospectus issu ...

Core Viewpoint - A class action securities lawsuit has been filed against SLM Corporation, alleging securities fraud that affected investors between July 25, 2025, and August 14, 2025 [1][2]. Group 1: Lawsuit Details - The complaint claims that SLM Corporation experienced a significant increase in early-stage delinquencies, which was not disclosed to investors [2]. - It is alleged that the defendants overstated the effectiveness of SLM's loss mitigation and loan modification programs, misleading investors about the company's stability [2]. - The public statements made by the defendants are said to have created a materially false and misleading impression regarding SLM's business operations and prospects [2]. Group 2: Investor Information - Investors who suffered losses during the specified time frame have until February 17, 2026, to request to be appointed as lead plaintiff [3]. - Participation in the lawsuit does not require serving as a lead plaintiff, and class members may be entitled to compensation without any out-of-pocket costs [3]. Group 3: Firm Background - Levi & Korsinsky has a history of securing hundreds of millions of dollars for shareholders and has been recognized as one of the top securities litigation firms in the United States for seven consecutive years [4]. - The firm has extensive expertise in complex securities litigation and employs over 70 staff members to support its clients [4].

NEW YORK, Jan. 06, 2026 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in Stride, Inc. ("Stride" or the "Company") (NYSE: LRN) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Stride investors who were adversely affected by alleged securities fraud between October 22, 2024 and October 28, 2025. Follow the link below to get more information and be contacted by a member of our team: https://zlk.com/pslra-1/stride-inc-lawsuit-submission-form ...